1. Home
  2. GKOS vs VAL Comparison

GKOS vs VAL Comparison

Compare GKOS & VAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$146.06

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Valaris Limited

VAL

Valaris Limited

HOLD

Current Price

$75.69

Market Cap

5.4B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
VAL
Founded
1998
1975
Country
United States
Bermuda
Employees
N/A
5070
Industry
Medical/Dental Instruments
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GKOS
VAL
Price
$146.06
$75.69
Analyst Decision
Strong Buy
Hold
Analyst Count
12
5
Target Price
$126.92
$64.00
AVG Volume (30 Days)
928.7K
937.3K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
N/A
Revenue This Year
$23.32
N/A
Revenue Next Year
$27.43
$15.76
P/E Ratio
N/A
$16.22
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$43.53
52 Week High
$148.62
$114.12

Technical Indicators

Market Signals
Indicator
GKOS
VAL
Relative Strength Index (RSI) 67.05 34.73
Support Level $96.44 $47.57
Resistance Level N/A $104.05
Average True Range (ATR) 5.65 2.96
MACD 1.60 -0.52
Stochastic Oscillator 98.92 19.92

Price Performance

Historical Comparison
GKOS
VAL

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About VAL Valaris Limited

Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.

Share on Social Networks: